183 related articles for article (PubMed ID: 29632703)
1. Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety.
Mishra SK; Gupta A; Patyal S; Kumar S; Raji K; Singh A; Sharma V
Int J Retina Vitreous; 2018; 4():13. PubMed ID: 29632703
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinical outcomes of raised intraocular pressure following intravitreal triamcinolone acetonide injection.
Singh P; Krishnaprasad R; Ayachit G; Joshi S
Rom J Ophthalmol; 2024; 68(1):37-44. PubMed ID: 38617725
[No Abstract] [Full Text] [Related]
3. Intravitreal steroids for macular edema in diabetes.
Rittiphairoj T; Mir TA; Li T; Virgili G
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis.
Mihalache A; Hatamnejad A; Patil NS; Popovic MM; Kertes PJ; Cruz-Pimentel M; Muni RH
Ophthalmologica; 2024; 247(1):19-29. PubMed ID: 37579730
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
[No Abstract] [Full Text] [Related]
6. Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion.
Fan C; Wang Y; Ji Q; Zhao B; Xie J
Curr Eye Res; 2014 Sep; 39(9):938-43. PubMed ID: 24635755
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial.
Mishra SK; Sinha S; Chauhan R; Kumar A
Curr Drug Deliv; 2021; 18(6):825-832. PubMed ID: 33267762
[TBL] [Abstract][Full Text] [Related]
9. Long-term Results of Ranibizumab, Dexamethasone Implant, and Triamcinolone in Macular Edema due to Branch Retinal Vein Occlusion.
Dikel NH; Yumusak E; Gokcinar NB
Beyoglu Eye J; 2019; 4(3):141-148. PubMed ID: 35187450
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion.
Gokce G; Sobaci G; Durukan AH; Erdurman FC
Postgrad Med; 2013 Sep; 125(5):51-8. PubMed ID: 24113663
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients.
Dang Y; Mu Y; Li L; Mu Y; Liu S; Zhang C; Zhu Y; Xu Y
Drug Des Devel Ther; 2014; 8():1441-9. PubMed ID: 25258512
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.
Gewaily D; Muthuswamy K; Greenberg PB
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD007324. PubMed ID: 26352007
[TBL] [Abstract][Full Text] [Related]
13. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
[TBL] [Abstract][Full Text] [Related]
14. Comparison of intravitreal injection of conbercept and triamcinolone acetonide for macular edema secondary to branch retinal vein occlusion.
Zhao M; Zhang C; Chen XM; Teng Y; Shi TW; Liu F
Int J Ophthalmol; 2020; 13(11):1765-1772. PubMed ID: 33215008
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
[TBL] [Abstract][Full Text] [Related]
16. Early results of dexamethasone implant, ranibizumab, and triamcinolone in macular edema due to branch retinal vein occlusion.
Yumusak E; Buyuktortop N; Ornek K
Eur J Ophthalmol; 2016; 26(1):54-9. PubMed ID: 26109021
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intravitreal bevacizumab with intravitreal triamcinolone acetonide for treatment of cystoid macular edema secondary to retinal vein occlusion: a Meta-analysis.
Sun Y; Qu Y
Int J Ophthalmol; 2015; 8(6):1234-9. PubMed ID: 26682180
[TBL] [Abstract][Full Text] [Related]
18. Triamcinolone intravitreal injection and intraocular pressure in macular edema associated with retinal vein occlusion.
Wei Y; Wang HZ; Chen FH; Wang RS; Yang XG
Eye Sci; 2012 Dec; 27(4):182-7. PubMed ID: 23225839
[TBL] [Abstract][Full Text] [Related]
19. Secondary glaucoma after intravitreal dexamethasone implant (Ozurdex) injection in patients with retinal disorder: A retrospective study.
Sweta VD; Shibi Dev BN; Sandhya R
Indian J Ophthalmol; 2022 Feb; 70(2):585-589. PubMed ID: 35086242
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jiao J; Li XY; Whitcup SM; ; Li J
Ophthalmology; 2011 Dec; 118(12):2453-60. PubMed ID: 21764136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]